BSC
IBB icon

BOLTON SECURITIES CORPORATION’s iShares Biotechnology ETF IBB Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$230K Sell
1,208
-32,580
-96% -$5.6M 0.01% 861
2026
Q1 		$5.71M Buy
+33,788
New +$5.78M 0.27% 79
2025
Q3 		$4.74M Buy
+32,844
New +$4.48M 0.22% 110
2025
Q1 		$109K Buy
+853
New +$116K 0.01% 846

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Commerce Bank
Commerce Bank Kansas City, Missouri $22.9B AUM 22.61% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's IBB Position: Q2 2026 in Review

BOLTON SECURITIES CORPORATION reduced its iShares Biotechnology ETF (IBB) stake by 96% in Q2 2026, selling an estimated $5.6M and leaving 1,208 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #861.

BOLTON SECURITIES CORPORATION first reported a position in IBB in Q1 2025 and has held it in 4 quarters since. The position peaked at $5.71M in Q1 2026. 963 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • BOLTON SECURITIES CORPORATION held 1,208 shares of iShares Biotechnology ETF worth $230K as of Q2 2026.
  • BOLTON SECURITIES CORPORATION sold 32,580 iShares Biotechnology ETF shares in Q2 2026, an estimated $5.6M.
  • iShares Biotechnology ETF made up 0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q2 2026, its #861 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in iShares Biotechnology ETF in Q1 2025 and has held it in 4 quarters since.
  • BOLTON SECURITIES CORPORATION's iShares Biotechnology ETF position peaked at $5.71M in Q1 2026.
  • 963 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q2 2026, filed 12 Nov 2026.